Cite
Pollinger J, Schierle S, Gellrich L, et al. A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences. ACS Med Chem Lett. 2019;10(9):1346-1352doi: 10.1021/acsmedchemlett.9b00306.
Pollinger, J., Schierle, S., Gellrich, L., Ohrndorf, J., Kaiser, A., Heitel, P., Chaikuad, A., Knapp, S., & Merk, D. (2019). A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences. ACS medicinal chemistry letters, 10(9), 1346-1352. https://doi.org/10.1021/acsmedchemlett.9b00306
Pollinger, Julius, et al. "A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences." ACS medicinal chemistry letters vol. 10,9 (2019): 1346-1352. doi: https://doi.org/10.1021/acsmedchemlett.9b00306
Pollinger J, Schierle S, Gellrich L, Ohrndorf J, Kaiser A, Heitel P, Chaikuad A, Knapp S, Merk D. A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences. ACS Med Chem Lett. 2019 Aug 16;10(9):1346-1352. doi: 10.1021/acsmedchemlett.9b00306. eCollection 2019 Sep 12. PMID: 31531208; PMCID: PMC6746191.
Copy
Download .nbib